Physician profile
Danielle L Moller
NPI 1447566302
$5,775.07
in general payments reported to CMS, 2019-2025
18 companies · $3,061 in 2025
The $3,061 reported for 2025 was more than what 98% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $1,028 · 2023: $788 · 2024: $688 · 2025: $3,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,277 · Food and Beverage: $2,224 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,276.97 |
| Food and Beverage | $2,224.32 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,249.37 | 2022-2025 | Rezum Generator, Ams 700 |
| Medtronic, INC. | $1,178.61 | 2024-2025 | Interstim |
| Teleflex LLC | $1,072.27 | 2021-2025 | Urolift, Barrigel |
| Smith+Nephew, INC. | $948.79 | 2022-2025 | Stravix, Grafix Pl, Stravix Pl |
| Myriad Genetic Laboratories, INC. | $242.70 | 2021-2023 | Prolaris |
| Axonics, INC. | $228.69 | 2022-2023 | Axonics, Bulkamid |
| Coloplast Corp | $188.79 | 2023-2024 | Speedicath |
| Janssen Biotech, INC. | $140.80 | 2025 | Rybrevant, Carvykti |
| Astellas Pharma US INC | $138.59 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $125.00 | 2023 | Xiaflex |
| Calyxo, INC. | $76.83 | 2023-2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $40.78 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $28.60 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $27.50 | 2025 | Purewick Female External Catheter |
| Progenics Pharmaceuticals, INC. | $26.50 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.66 | 2023 | |
| Myovant Sciences INC. | $19.79 | 2021 | |
| Ambu INC. | $16.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Moller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.